CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
CERE
Delisted
CERE was delisted on the 31st of July, 2024.
210 hedge funds and large institutions have $6.67B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 82 increasing their positions, 49 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more capital invested
Capital invested by funds: $6.64B → $6.67B (+$31.3M)
9% less funds holding in top 10
Funds holding in top 10: 11 → 10 (-1)
Holders
210
Holding in Top 10
10
Calls
$60M
Puts
$47.1M
Top Buyers
| 1 | +$82M | |
| 2 | +$63.6M | |
| 3 | +$58.5M | |
| 4 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$47.3M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$38.4M |
Top Sellers
| 1 | -$334M | |
| 2 | -$89.9M | |
| 3 | -$42.2M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$36.5M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$33.3M |